Sllmmary
Allografts of the liver, which has a comparatively heavy leukocyte content compared with other vascularized organs, are accepted permanently across major histocompatibility complex barriers in many murine strain combinations without immunosuppressive therapy. It has been postulated that this inherent tolerogenicity of the liver may be a consequence of the migration and perpetuation within host lymphoid tissues of potentially tolerogenic donor-derived ("chimeric") leukocytes, in particular, the precursors of chimeric dendritic cells (DC) . In this study, we have used granulocyte/macrophage colony-stimulating factor to induce the propagation of progenitors that give rise to DC (CD45 +, CDllc + , 33D1 +, nonlymphoid dendritic cell 145 +, major histocompatibility complex class II +, B7-1 +) in li~tuid cultures of murine bone marrow cells. Using this technique, together with immunocytochemical and molecular methods, we show that, in addition to cells expressing female host (C3H) phenotype (H-2Kk+; I-E+; Y chromosome-), a minor population of male donor (B10)-derived cells (H-2Kb+; I-A+; Y chromosome +) can also be grown in 10-d DC cultures from the bone marrow of liver allograft recipients 14 d after transplant. Highly purified nonlymphoid dendritic cell 145 + DC sorted from these bone marrow-derived cell cultures were shown to comprise ~1-10% cells of donor origin (Y chromosome +) by polymerase chain reaction analysis. In addition, sorted DC stimulated naive, recipient strain T lymphocytes in primary mixed leukocyte cultures. Evidence was also obtained for the growth of donor-derived cells from the spleen but not the thymus. In contrast, donor ceils could not be propagated from the bone marrow or other lymphoid tissues of nonimmunosuppressed C3H mice rejecting cardiac allografrs from the same donor strain (B10). These findings provide a basis for the establishment and perpetuation of cell chimerism after organ transplantation.
n unresolved enigma with the recent demonstration of persistent low-level donor leukocyte chimerism after organ transplantation (1-4) has been the means by which the chimeric cells can be perpetuated up to many years (2) postoperatively. Both in rodents (5-7) and in humans (8) , dendritic cells (DC), 1 which have well-recognized in vivo migratory ability (9) (10) (11) (12) , feature prominently in immunohistochemical analyses of this multilineage chimerism in long-term successful organ recipients. For some time, it has been recognized that DC in lymphoid and other organs arise from proliferating bone marrow--derived precursors (13) (14) (15) . Only recently, how-1 Abbreviations used in this paper: DC, dendritic cells; NPC, liver nonparenchymal cells; OLTx, orthotopic liver transplantation. ever, have in vitro systems been developed for inducing the growth of these cells from precursors present in either the blood (16) or bone marrow (17) . Similar methods have confirmed the presence of DC progenitors within the spleen (18) or liver (19) . In each of these systems, liquid culture has been used to generate DC under the aegis of GM-CSF. This approach has permitted extensive characterization of the progeny DC, including their structural features, motility, immunophenotype, aUostimulatory activity, and in vivo homing ability. With respect to murine liver-derived DC progenitors, it has been shown that their injection into nonimmunosuppressed allogeneic recipients gives rise to strongly MHC class IIpositive cells that persist for months within T-dependent areas of secondary lymphoid tissue (20) .
In mice, liver but not other organ allografts are accepted permanently and with donor specificity between many strain combinations, without the requirement for immunosuppression (6) . Here we present evidence that liver allografts export DC precursors that can be propagated in GM-CSF from the bone marrow or spleen of unmodified recipients. This novel finding, together with failure to propagate donor cells from the lymphoid tissues of nonimmunosuppressed mice rejecting cardiac allografts from the same donor strain, is congruent with the possibility that bidirectional leukocyte migration and donor cell chimerism play key roles in organ graft acceptance and acquired transplantation tolerance.
Materials and Methods
Animals. 10-12-wk-old male C57BL/10J mice (B10; H-28, I-A b, I-E-) and C3H/HeJ (C3H; H-2 k, I-A k, I-E k) mice of both sexes were purchased from The Jackson Laboratory (Bar Harbor, ME). They were maintained in the specific pathogen-free facility of the University of Pittsburgh Medical Center (Pittsburgh, PA).
Liver and Heart Transplantation. Orthotopic liver transplantation (OLTx) was performed in a mouse strain combination (B10 to C3H; MHC class I, II and multiple non-MHC antigen disparities) with a high liver acceptance rate (6), using techniques described previously (21) with minor modifications. Briefly, after damping the artery and portal vein, the donor liver was flushed thoroughly via the portal vein with cold lactated Ringer's solution. A suprahepatic vena cava anastomosis was completed, with a 10-0 running suture. The cuff technique was used for anastomosis of both the intrahepatic vena cava and the portal vein. No attempt was made to reconstruct the graft arterial supply. The bile ducts were annealed by inserting a polyethylene tube into both. Blood lost during the operation was replaced with lactated Ringer's solution. The method for heterotopic heart transplantation was adapted from the rat procedure of Ono and Lindsey (22) . The heart was transplanted into the abdomen with end to side anastomosis of aorta to aorta and pulmonary artery to vena cava. Rejection was defined by the cessation of cardiac contraction after daily palpation through the abdominal wall, and it was confirmed by histological examination. No immunosuppressive therapy was used in either procedure, and the animals (three per group in each experiment) were killed 14 d after OLTx or 8 d after heart transplantation.
Isolation of Leukocytes from Tissues.
Before harvesting of organs from transplanted animals, whole body perfusion was performed to minimize blood contamination of tissues. 30 ml HBSS (GIBCO BRL, Gaithersburg, MD) was infused over a 3-min period via the inferior vena cava. Bone marrow cell suspensions and mononuclear cells from the spleen or thymus were prepared in RPMI 1640 (GIBCO BILL) using conventional methods. Liver nonparenchymal cells (NPC) (<5% hepatocyte contamination) were isolated as described in detail elsewhere (19) . Briefly, the liver was perfused in situ via the portal vein with collagenase solution (type IV, 1 mg/ml in HBSS; Sigma Chemical Co., St. Louis, MO). It was then removed, diced, and further digested with collagenase in vitro. The washed cells were then centrifuged on Percoll (Sigma Chemical Co.) gradients, and the leukocyte-rich layer was harvested as described (19) . . Staining with primary hamster or rat mAbs, including rat anti-B7-1 and -B7-2 (Pharmingen, San Diego, CA) was followed by FITCconjugated goat anti-hamster or mouse anti-rat Igs as described (18, 19) . Donor and recipient MHC class I-and class II-positive calls were identified using biotin-conjugated mouse anti-mouse mAbs (Pharmingen, San Diego, CA) with FITC streptavidin (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) as the secondary reagent. After staining, the ceils were fixed in 1% paraformaldehyde in saline before analysis, mAbs to MHC class II antigens and to the 2A1 DC-restricted granule antigen were tested on cytospin preparations as described (17, 18) . The specimens were fixed in acetone and stained with biotinylated mouse anti-MHC class II or rat anti-2A1 mAbs, followed by streptavidin biotin peroxidase complex (ABC-P; Boehringer Mannheim Corp., Indianapolis, IN) or peroxidase-conjugated anti-rat Ig, respectively. The nuclei were counterstained with hematoxylin.
Culture of Tissue-derived Cells with GM-CSE

Detection of Donor Male (Y) Chromosome in Cell
Cultures by PCR Analysis. DNA was prepared from freshly isolated and 10-d GM-CSF-stimulated cells from both normal male B10 and female C3H mice and from female C3H mice 14 or 8 d, respectively, after liver or heart transplantation from male B10 donors. The presence of male donor cells was determined as previously described for human analysis (24) by PCR amplification of the SRY region of the mouse Y chromosome. Primers (5'-CAGCCCTACAGCCACAT-3' and 5'-CCACTCCTCTGTGACACTTT-3') were chosen from the p4.2.2 sequence (25). 1-/zg aliquots of DNA were amplified with 30 cycles at 94~ for 30 s, 55~ for 30 s, and 72~ for 30 s in buffer consisting of 50 mM KC1, 10 mM Tris-HC1, pH 8.3, 1.5 mM MgC12, 0.2 mM deoxynucleotides, 0.1% gelatin, 0.2 #M primers, and 2.5 U of Taq polymerase (Perkin-Elmer Corp., Norwalk, CT). The products were separated in a 1% agarose gel, transferred to nylon membrane, and hybridized with an identical purified and radiolabeled 32p PCR product from male mouse DNA. Singlecopy sensitivity and male specificity were verified with control samples consisting of serial dilutions of male mouse DNA into that of female mouse DNA. The Rockefeller University, New York) or rat IgG2a isotype control (Sigma Chemical Co.) was added, and cells were incubated for 45 min at 4oC. After two washes in HBSS, the cells were stained with FITC-conjugated goat anti-rat IgG (Sigma Chemical Co.) under the same conditions. They were then washed and resuspended in complete KPMI 1640 medium supplemented with 2% FCS (GIBCO BRL) for cell sorting. NLDC 145 + and NLDC 145-cells were sorted into distinct cell populations based on forward scatter, side scatter, and FITC fluorescence intensity using a FACStar Plus | cell sorter (Becton Dickinson & Co.). Cells were excited with a 5-mW argon/HeNe laser (Coherent Inc., Palo Alto, CA) attaining purities of both populations >90%.
Sorting of DC.
Mixed Leukocyte Cultures.
To test the allostimulatory activity of cultured, bone marrow-derived cells, one-way mixed leukocyte cultures (2 x 1@ responder cells per well in 96-well, round-bottom microculture plates) were performed. Various numbers of 3~-irradiated (20 Gy) stimulator cells propagated with GM-CSF plus I1.4 from donor (B10) or recipient (C3H) strain animals or from the bone marrow of liver aUograft recipients were added. As an aid to determining the incidence of donor-derived allostimulatory cells propagated from graft recipients, "artificial" mixtures of cultured donor (1-10%) and recipient strain bone marrow-derived cells were also used as stimulators. C3H or B10 spleen cells were used as responders, which were T cell enriched by sequential removal of plastic adherent cells (1 h at 370C) and by passage (1 h) through a nylon wool column. Cultures were maintained in RPMI 1640 complete medium supplemented with 10% heat-inactivated FCS for 72 h in 5% CO2 in air; for the final 18 h, 10 #1 [3H]TdR.
(1 #Ci) was added to each well. Cells were harvested onto glass fiber disks using a multiple cell harvester, and the degree of thymidine incorporation was determined in a liquid scintillation counter. Results were expressed as mean cpm _+ 1 SD.
Results
Propagation of DC from Normal Mouse Bone Marrow.
In prior studies, aggregates of growing DC progenitors were described in cultures established from mouse liver or spleen cell suspensions (18, 19) using procedures modified after Inaba and co-workers (16, 17) . Similar techniques were adopted to propagate DC progenitors from the bone marrow of B10 and C3H mice. At 2 and 4 d of culture, non-or loosely adherent granulocytes were removed, without dislodging clusters of developing DC that were attached to firmly plastic-adherent macrophages. After day 4, granulocytes were no longer significant contaminants, and the cultures were maintained routinely for 10 d. Numerous dendritic-shaped cells appeared to be released from the clusters. These floating cells exhibited typical dendritic projections and other structural features of DC (17, 19, 26) upon light microscopic examination. adhesion molecule-I), CD11b (membrane attack complex-I), and CD44 (nonpolymeric determinant of Pgp.1 glycoprotein). In addition, staining of moderate intensity was observed for the routine DC-restricted markers NLDC 145 (interdigitating cells), 33D1, and CD11c (N418; B2-integrin); for the macrophage antigen F4/80; and for Fc3'RII, as described previously (17) for bone marrow-derived DC. The cells also expressed moderate levels of MHC class II and of the costimulatory molecule and CD28 ligand, B7-1. The cells were negative, however, for cell surface expression of the CD28 coligand B7-2. Expression of the low affinity IIr receptor (CD25) could also not be demonstrated (data not shown).
Immunophenotypic Analysis of GM-CSF-stimulated
Cytospins were prepared to further characterize the released DC. By day 10, the majority of the cells were dendritic by Giemsa stain and expressed high levels of MHC class II. Granulocytcs were rare. The majority of the cells strongly expressed the DC-restricted granule antigen 2A1 (17, 18) . Similar results were obtained whether the cultures were established from cells obtained from the bone marrow of either B10 or C3H mice.
Detection of Cells Expressing Donor Phenotype in Freshly Isolated Bone
Marrow from Liver Allografi Recipients. C3H mice accept livers from B10 donors spontaneously, with graft survival times consistently >100 d (6) . To identify cells expressing donor phenotype in freshly isolated bone marrow cell suspensions obtained from nonimmunosuppressed C3H mice 14 d after OLTx from B10 donors, mAbs directed against donor (H-2 b) and recipient (H-2 k) MHC class I antigens were used. Typically, as shown in Fig. 1 (left) , the incidence of cells expressing donor MHC class I determined by flow cytometry in allografted mice was very low ('-1%), whereas that of recipient was, as expected, consistently very high (>84%).
Cells Expressing Donor Phenotype in Bone Marrow DC Cultures from Liver Allografi Recipients. We next determined
whether DC expressing donor cell surface phenotype could be propagated using GM-CSF from postulated small numbers of progenitor cells in freshly isolated bone marrow of unmodified liver allograft recipients. As shown in Fig. 1 (right), both cells expressing recipient (H-2K k+) and those expressing donor MHC class I (H-2K b+) could be identified by cytofluorometry in 10-d cultures propagated using the same methods as for DC from normal bone marrow. Staining of cytospins for recipient and donor MHC class II products confirmed the presence of small numbers of donor (I-A b+) cells (Fig. 2) . In several repeat experiments using pooled bone marrow cells from groups of three allograft recipients, the incidence of donor MHC class II + cells in 10-d GM-CSFstimulated cultures ranged from 5 to 17%.
Detection of Donor Y Chromosome in GM-CSF-stimulated
Cultures from Liver Allografi Recipients. The apparent incidence of donor-derived DC in GM-CSF-stimulated bone marrow cell cultures was comparatively low. Therefore, to eliminate the possibility of false positive results due to minimal antibody cross-reactivity or to the uptake of donor MHC products by recipient APC, PCR analysis for donor Y chromosome was performed on cells cultured from female (C3H) recipients of male (B10) liver grafts killed 14 d after transplant. Detection of Y chromosome (Fig. 3) growth of donor-derived cells in the 10-d bone marrow cell cultures and reinforced the immunocytochemical observations. Y chromosome signal was also detected in 10-d spleen cell cultures and was also increased in magnitude compared with freshly isolated cells. The signal, however, was substantially lower compared with bone marrow-derived cells (Fig. 3) , indicating that comparatively few donor-derived, GM-CSFresponsive DC precursors had reached the spleen. A diminished signal for donor (male) cells in 10-d GM-CSF-stimulated liver-derived cell populations (Fig. 3 ) may reflect the deliberate physical removal and also the death of contaminating male hepatocytes (<5% at the initiation of the cultures). In addition, in situ replacement of donor (male) with host (female) GM-CSF-responsive cells within the liver by day 14 after transplant (5, 6), when the cells were freshly isolated, may contribute to the relative reduction in the donor signal from cultured liver-derived cells on day 10. In contrast to bone marrow and spleen, and despite histological findings (5) and evidence for chimerism in freshly isolated thymus cell suspensions, no signal for donor-derived cells could be detected in 10-d GM-CSF-stimulated cultures of thymocytes from liver allograft recipients. This suggested that, although a site in which chimeric cells are detected after OLTx, the thymus may not be a destination for adequate numbers of donor-derived immature DC progenitors.
Evidence that the Donor-derived Cells are DC. We next sought direct evidence that the donor-derived cells propagated from the bone marrow of liver allograft recipients were DC. Sorting Fig. 5 A, the purified NLDC 145 + population propagated from C3H recipients of B10 allografts strongly stimulated B10 responders but also stimulated a response in recipient strain T cells (Fig. 5 B) . The extent of stimulation (P <0.01 compared with negatively sorted cells or syngeneic DC) was similar to that achieved with "artificial mixtures" containing 1% donor strain DC.
Failure to Propagate Donor-derived Cells from Bone Marrow of Mice Rejecting Heart
Allografts. In contrast to liver allograft recipients, nonimmunosuppressed C3H mice reject heart allog, rafts from the same donor strain (B10) within 8 d (6). PCR analysis for donor Y chromosome was performed on 10-d GM-CSF-stimulated cultures of bone marrow cells harvested from heterotopic cardiac allograft recipients 8 d after transplant. In contrast to the results obtained from liver graft recipients, no evidence was obtained for the propagation of donor-derived cells from the bone marrow of animals rejecting their cardiac grafts (Fig. 6) , despite evidence of chimeric cells in freshly isolated bone marrow. It thus appears that these heart-derived cells, in contrast to those detected in fresh bone marrow of liver allograft recipients, do not comprise sufficient numbers of GM-CSF-responsive progenitors to allow growth 383 Lu et al. 
Discussion
In a previous search for myeloid progenitors in normal mouse liver using the same methods subsequently adopted in this study, ceils were propagated with GM-CSF that exhibited many characteristics of DC (19) . These included the expression of murine DC-restricted cell surface immunophenotypic markers (27) . The ceils did not, however, conform to the stereotypic features dassicaUy associated with ma- ture murine DC (11, 15, 25) . Thus, they were MHC Class II -/dim in contrast to MHC class II b~ight spleen-derived DC propagated under similar conditions, and they were poor stimulators of allogeneic T cells. They thus resembled immunologically immature DC (15, 28) . When, however, these cells were exposed to the liver microenvironmental extracellular matrix protein type I collagen for 3-4 d in the continued presence of GM-CSF, they assumed more mature DC characteristics. These included strong cell surface MHC class II expression, loss of phagocytic ability, and acquisition of potent aUostimulatory activity (19) . In addition, we observed that 1 to at least 60 d after these immature DC progenitors were injected locally or systemically into MHC and non-MHC disparate recipients, donor cells that were MHC class II bright could be detected readily within T cell areas of the host's lymphoid tissues (20) . These observations suggested, amongst other implications, a mechanism for liver DC precursor expansion and a possible basis for the establishment and perpetuation of donor-derived cell microchimerism after OLTx. The findings have now been extended to the context of whole organ transplantation. In the present study, an MHC class I-and II-disparate mouse strain combination (B10 -~ C3H) that accepts liver grafts spontaneously was used to determine whether liver-derived DC progenitors could be propagated from recipient lymphoid tissue. To confirm the presence of donor-derived cells, we first examined with flow cytometry the frequency of donor and recipient MHC class I + leukocytes in freshly isolated cell suspensions from the bone marrow, spleen, thymus, and liver 14 d after OLTx. As anticipated, donor class I § cells were rare (~<1%) in the freshly isolated cell populations isolated from recipient primary and secondary lymphoid tissues. A higher incidence of donor class I + NPC (5-9%) was detected in the liver aUograft itself. When, however, cells were harvested from recipient bone marrow 14 d after OLTx and then cultured for 10 d in GM-CSF, a significant proportion of the developing DC exhibited donor phenotype. The same phenomenon was observed with cells propagated from the spleen, although the apparent growth of donor-derived DC was less striking. The expression of MHC class II on these cells could most accurately be studied after immunochemical staining of cytospin preparations. Similar to the class I results, donor class II + cells were readily detected in the GM-CSFstimulated cultures from bone marrow and spleen, both of which are hemopoietic tissues. In contrast, although donor class I § and II § cells were also detected in freshly isolated thymocyte preparations, it proved consistently difficult to demonstrate ex vivo growth of DC progenitors from the thymuses of liver-allografted mice.
Definitive evidence for the growth of donor liver-derived 384 Growth of Donor-derived Dendritic Cells from Allograft Recipients cells from the bone marrow (especially) and spleen was obtained by detection of the presence of the (donor) Y chromosome by PCR. amplification and Southern blotting. These revealed a level of chimerism in the GM-CSF-stimulated cultures of ,,o1-10% (Fig. 3) . Definitive evidence that donorpositive cells were DC was obtained by demonstration of the Y chromosome (Fig. 4) and allostimulatory activity for recipient strain naive T cells (Fig. 5 B) in highly purified NLDC 145 + cell populations. In marked contrast to these findings, donor-derived cells could not be propagated from the bone marrow, spleen, or thymus of unmodified cardiac allograft recipients rejecting their transplants at 8 d. Although donorderived cells were detected in the freshly isolated bone marrow, these cells clearly did not comprise sufficient numbers of GM-CSF-responsive cells to allow perpetuation of donor signal for 10 d in culture. An implication of these observations is that acceptance of an organ allograft may be dependent on sustained chimerism comprising sufficient numbers of the appropriate donor-derived progenitor cell population(s).
Our observations appear to explain the persistence of lowlevel chimerism that does not require host immunosuppression in the B10 "~ C3H liver transplant model. They are also consistent with the adult liver containing comparatively large numbers of (potential migratory) hemopoietic cells (29) , including DC progenitors with the capacity to propagate ex vivo in response to appropriate growth factors. The observation that organ transplantation permits the growth of donor as well as recipient progenitor DC is congruent with the paradigm of bidirectional immune reactivity, which, we have suggested, may explain whole-organ graft acceptance and acquired tolerance in a different way than previously envisioned (1, 5, 6, 8, 30) . We postulate that the peripheral tissues and the graft itself become repositories of precursor cells of myeloid and probably other lineages, or perhaps even of pluripotent stem cells. The presence of these precursor cells can potentially be identified, as in this study, by their patterns of differentiation under controlled culture conditions.
The functional role of the precursors of chimeric DC is currently being investigated. Others have demonstrated a veto function for either subpopulations of murine DC (31) or putative immature DC in primate allogeneic bone marrow (32, 33) . Moreover, there is strong evidence that the reduction of MHC class I-specific cytotoxic responses in mice injected with allogeneic donor lymphoid cells is a function of donordeletional APC that inactivate class I-reactive CTL precursors that recognize them (34) . The presence of donor-derived DC for up to I yr in rodents tolerant to their allografts (5, 6) and for many years after OLTx in humans (2) has been demonstrated. Moreover, using techniques described in the present study, we have preliminary evidence that donor-derived cells can be propagated from the bone marrow of unmodified murine liver allograft recipients up to 5 mo after transplant (our unpublished observations). The magnitude, tissue-specific site dependency, replicative capacity, and maturational stage of chimeric DC (including cell surface expression of key T ceUcostimulatory molecules [35, 36] ) that may be necessary to mediate postulated tolerizing effects of these cells have not been established.
Our failure to propagate chimeric DC progenitors from the thymus is of particular interest. Previous reports have shown that either intrathymic (37) or intravenous (38) donor bone marrow cell infusion in antilymphocyte serum/antithymocyte globulin-treated mice results in only a comparatively low level of thymic chimerism that can no longer be detected after 3 wk. Indeed, permanent cardiac graft survival in mice is maintained despite the apparent absence of donor bone marrow cell-derived chimerism in the thymus (37) . Moreover, the thymus is not required for the induction of liver-induced transplantation tolerance (39) . Thus, chimerism in the periphery may be more important in maintaining a tolerant state (40--42) . Conceivably, the recipient bone marrow may provide a repository of donor-derived DC progenitors with the potential to migrate to key peripheral sites. The unique observations in this study provide an opportunity for elucidation of the role of donor-derived cells in the induction and maintenance of donor-specific unresponsiveness after organ transplantation.
